RxDoctor Payments Data

Heather Chaney

Family · Toledo, OHNPI 1528796836

Payments from drug & device makers

$1,023in general payments, 2019–2025

Across 41 payments — averaging $24.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$133
  • AbbVie$111
  • EMD Serono, Inc.$105
  • Seagen Inc.$80
  • Teleflex LLC$80
  • Urogen Pharma, Inc.$74
  • plus $441 from 13 others

What the payments were for

  • Food & beverage$94392%
  • Education$808%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,023 in reported general payments places this provider in the 70th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$26,194
Medicare patients
293
Services billed
1,005

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron439$335,909
GemtesaVibegron215$164,896
Mirabegron ErMirabegron67$61,775
OrgovyxRelugolix19$51,387
Tamsulosin Hcl1,992$43,929
Solifenacin Succinate235$24,292
Trospium Chloride ErTrospium Chloride94$17,181
Oxybutynin Chloride ErOxybutynin Chloride420$12,081
Potassium Citrate ErPotassium Citrate120$11,726
Finasteride813$10,953
XyostedTestosterone Enanthate17$10,173
Methenamine Hippurate104$8,562
Alfuzosin Hcl ErAlfuzosin Hcl376$8,258
Estradiol58$7,911
Tolterodine Tartrate ErTolterodine Tartrate60$7,784

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa, Orgovyx$133$216,283234 claims
Antares Pharma, Inc.Xyosted$68$10,17317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,812 family providers in Ohio.

Other family in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →